[1]
|
Huang, X.F., Wang, K.Y., Liang, Z.H., Du, R.R. and Zhou, L.N. (2015) Clinical Analysis of Patients with Primary Blepharospasm: A Report of 100 Cases in China. European Neurology, 73, 337-341.
https://doi.org/10.1159/000381707
|
[2]
|
Valls-Sole, J. and Defazio, G. (2016) Blepharospasm: Update on Epidemiology, Clinical Aspects, and Pathophysiology. Frontiers in Neurology, 7, 45. https://doi.org/10.3389/fneur.2016.00045
|
[3]
|
Coscarelli, J.M. (2010) Essential Blepharospasm. Seminars in Ophthalmology, 25, 104-108.
https://doi.org/10.3109/08820538.2010.488564
|
[4]
|
Jankovic, J., Kenney, C., Grafe, S., Goertelmeyer, R. and Comes, G. (2009) Relationship between Various Clinical Outcome Assessments in Patients with Blepharospasm. Movement Disorders: Official Journal of the Movement Disorder Society, 24, 407-413. https://doi.org/10.1002/mds.22368
|
[5]
|
Mezaki, T., Kaji, R., Brin, M.F., Hirota-Katayama, M., Kubori, T., Shimizu, T., et al. (1999) Combined Use of Type A and F Botulinum Toxins for Blepharospasm: A Double-Blind Controlled Trial. Movement Disorders: Official Journal of the Movement Disorder Society, 14, 1017-1020.
https://doi.org/10.1002/1531-8257(199911)14:6<1017::AID-MDS1018>3.0.CO;2-3
|
[6]
|
Sung, Y., Nam, S.M. and Lew, H. (2015) Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm. Korean Journal of Ophthalmology: KJO, 29, 115-120.
https://doi.org/10.3341/kjo.2015.29.2.115
|
[7]
|
Karttunen, P., Tukiainen, H., Silvasti, M. and Kolonen, S. (1987) Antitussive Effect of Dextromethorphan and Dextromethorphan-Salbutamol Combination in Healthy Volunteers with Artificially Induced Cough. Respiration; International Review of Thoracic Diseases, 52, 49-53. https://doi.org/10.1159/000195303
|
[8]
|
Bokesch, P.M., Marchand, J.E., Connelly, C.S., Wurm, W.H. and Kream, R.M. (1994) Dextromethorphan Inhibits Ischemia-Induced c-fos Expression and Delayed Neuronal Death in Hippocampal Neurons. Anesthesiology, 81, 470-477. https://doi.org/10.1097/00000542-199408000-00026
|
[9]
|
Huang, E.Y., Liu, T.C. and Tao, P.L. (2003) Co-Administration of Dextromethorphan with Morphine Attenuates Morphine Rewarding Effect and Related Dopamine Releases at the Nucleus Accumbens. Naunyn-Schmiedeberg’s Archives of Pharmacology, 368, 386-392. https://doi.org/10.1007/s00210-003-0803-7
|
[10]
|
Chen, S.L., Hsu, K.Y., Huang, E.Y., Lu, R.B. and Tao, P.L. (2011) Low Doses of Dextromethorphan Attenuate Morphine-Induced Rewarding via the Sigma-1 Receptor at ventral Tegmental Area in Rats. Drug and Alcohol Dependence, 117, 164-169. https://doi.org/10.1016/j.drugalcdep.2011.01.013
|
[11]
|
Ohi, Y., Tsunekawa, S. and Haji, A. (2011) Dextromethorphan Inhibits the Glutamatergic Synaptic Transmission in the Nucleus Tractus Solitarius of Guinea Pigs. Journal of Pharmacological Sciences, 116, 54-62.
https://doi.org/10.1254/jphs.11008FP
|